(R)-1-((1H-Imidazol-4-yl)methyl)-3-benzyl-4-(thiophen-2-ylsulfonyl)-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carbonitrile hydrochloride
97%
- Product Code: 113429
CAS:
195981-08-9
Molecular Weight: | 526.0700000000001 g./mol | Molecular Formula: | C₂₅H₂₄ClN₅O₂S₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | room temperature, dry |
Product Description:
This chemical is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. Its structure suggests potential activity in targeting specific receptors or enzymes, making it valuable for research in neurological or psychiatric disorders. The presence of the imidazole and benzodiazepine moieties indicates its potential use in designing compounds for anxiety, insomnia, or other central nervous system-related conditions. Additionally, the thiophene sulfonyl group may contribute to its binding affinity or pharmacokinetic properties, enhancing its efficacy in drug formulations. Researchers often explore derivatives of this compound to optimize its pharmacological profile for clinical applications.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.025 | 10-20 days | Ft147,389.80 |
+
-
|
(R)-1-((1H-Imidazol-4-yl)methyl)-3-benzyl-4-(thiophen-2-ylsulfonyl)-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carbonitrile hydrochloride
This chemical is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. Its structure suggests potential activity in targeting specific receptors or enzymes, making it valuable for research in neurological or psychiatric disorders. The presence of the imidazole and benzodiazepine moieties indicates its potential use in designing compounds for anxiety, insomnia, or other central nervous system-related conditions. Additionally, the thiophene sulfonyl group may contribute to its binding affinity or pharmacokinetic properties, enhancing its efficacy in drug formulations. Researchers often explore derivatives of this compound to optimize its pharmacological profile for clinical applications.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :